Literature DB >> 15730864

Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures.

L Cristiano1, A Cimini, S Moreno, A M Ragnelli, M Paola Cerù.   

Abstract

Peroxisome proliferator-activated receptors (PPARs), retinoid X receptors (RXRs), CCAAT/enhancer binding proteins (C/EBPs) and beta-catenin are transcription factors involved in cell differentiation. The aim of this work was to investigate the occurrence and variations of these proteins during astrocyte differentiation. Primary cultures of mouse cortical astrocytes were characterized using nestin, A2B5 and glial fibrillary acidic protein (GFAP) as differentiation markers, during a period of 21 days in vitro (DIV). Glycogen and triglyceride accumulation were also studied. At 3 DIV the cultures were mainly constituted by neural progenitor cells, as assessed by their immunofluorescent pattern. At this time PPARs and beta-catenin were localized to the cytoplasm. Interestingly, some cells contained Oil Red O-positive lipid droplets. Between 7 and 21 DIV, nestin decreased, while GFAP increased, indicating ongoing astroglial differentiation. beta-catenin, predominantly nuclear at 7 DIV, later localized to membranes. Redistribution of all three PPAR isotypes from the cytoplasm to the nucleus was observed starting from 7 DIV. Between 7 and 14 DIV, C/EBPalpha, PPARalpha, RXRalpha and glycogen content increased. Between 14 and 21 DIV, PPARbeta/delta decreased, while PPARgamma, C/EBPbeta and delta and lipid droplet-containing cells increased. At 21 DIV both A2B5-/GFAP+ and A2B5+/GFAP+ cells were predominantly observed, indicating differentiation toward type-1 and type-2 astrocytes, although the presence of GFAP- cells demonstrates the persistence of neural precursors in the culture even at this time point. In conclusion, our results, reporting modifications of PPARs, RXRs, C/EBPs and beta-catenin during culture time, strongly suggest the involvement of these transcription factors in astrocyte differentiation. Specifically, beta-catenin translocation from the nucleus to plasma membrane, together with PPARbeta/delta decrease and C/EBPalpha increase, could be related to decreased proliferation at confluence, while PPARalpha and gamma and all C/EBPs could participate in differentiation processes, such as glycogenesis and lipidogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15730864     DOI: 10.1016/j.neuroscience.2004.11.008

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

Review 1.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

2.  Roles of PPAR transcription factors in the energetic metabolic switch occurring during adult neurogenesis.

Authors:  E Di Giacomo; E Benedetti; L Cristiano; A Antonosante; M d'Angelo; A Fidoamore; D Barone; S Moreno; R Ippoliti; M P Cerù; A Giordano; A Cimini
Journal:  Cell Cycle       Date:  2016-11-18       Impact factor: 4.534

3.  Peroxisome proliferator-activated receptor-γ (PPAR-γ) activation confers functional neuroprotection in global ischemia.

Authors:  Zahra Fatehi-Hassanabad; R A Tasker
Journal:  Neurotox Res       Date:  2010-06-04       Impact factor: 3.911

4.  Transgenic analysis of GFAP promoter elements.

Authors:  Sujeong Yeo; Susanta Bandyopadhyay; Albee Messing; Michael Brenner
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

Review 5.  Metabolic and Inflammatory Adaptation of Reactive Astrocytes: Role of PPARs.

Authors:  José Iglesias; Ludis Morales; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-03-17       Impact factor: 5.590

6.  Palmitoylethanolamide prevents neuroinflammation, reduces astrogliosis and preserves recognition and spatial memory following induction of neonatal anoxia-ischemia.

Authors:  Mariana I Holubiec; Juan I Romero; Juan Suárez; Manuel Portavella; Emilio Fernández-Espejo; Eduardo Blanco; Pablo Galeano; Fernando Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  2018-07-29       Impact factor: 4.530

7.  Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-α.

Authors:  Marco Koch; Susanne Kreutz; Charlotte Böttger; Alexander Benz; Erik Maronde; Chalid Ghadban; Horst-Werner Korf; Faramarz Dehghani
Journal:  Neurotox Res       Date:  2010-03-11       Impact factor: 3.911

8.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

Review 9.  Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation.

Authors:  Annamaria Cimini; Maria Paola Cerù
Journal:  Stem Cell Rev       Date:  2008-06-17       Impact factor: 5.739

10.  PPARs in Human Neuroepithelial Tumors: PPAR Ligands as Anticancer Therapies for the Most Common Human Neuroepithelial Tumors.

Authors:  Elisabetta Benedetti; Renato Galzio; Barbara D'Angelo; Maria Paola Cerù; Annamaria Cimini
Journal:  PPAR Res       Date:  2010-03-17       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.